Cancer encompasses over 100 distinct types, each originating in different tissues and cells. Commonly known cancers include carcinoma, which arises in epithelial cells, and sarcoma, originating in bone, muscle, or connective tissues. Leukemia targets blood-forming tissues, disrupting normal blood cell production, while lymphoma and myeloma impact the immune system by affecting lymph nodes and plasma cells, respectively.
Recent advancements in cancer research are shedding light on rarer types, like neuroendocrine tumors and pediatric-specific cancers. Scientists are exploring molecular and genetic factors that distinguish each type, fostering breakthroughs in personalized medicine. This research is critical for developing targeted therapies that improve survival rates and quality of life for diverse cancer populations.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India